None listed
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: - a man over twenty years of age - Patients with erectile dysfunction with a history of diagnosis and treatment of diabetes with an HbA1C of 6.5 months or more - Subjects of the study who voluntarily participated in the clinical trial and the preparation of written consent forms
Exclusion criteria
Exclusion criteria: 1) Patients with myocardial infarction within the last 90 days. 2) Patients with unstable angina or angina during sexual intercourse 3) Patients with New York Heart Association Class 2 or higher heart failure in the last 6 months 4) Patients who had a stroke within the last six months. 5) Patients with hereditary degenerative retinopathy, including pigmented retinitis 6) Patients with hypersensitivity to PDE5 inhibitors. 7) Patients taking other PDE5 inhibitors. 8) Patients with genetic problems such as galactose intolerance, Lapp lactase deficiency, or glucose-galactose absorption disorder. 9) a patient with anterior ischemic optic neurosis 10) Patients administering the GC stimulant (Guanylate Cycle Stimulus).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Nailfold capillary microscopy | — |
Secondary
| Measure | Time frame |
|---|---|
| IIEF-5 Before and After Questionnaire | — |
Countries
Korea, Republic of
Contacts
Soon Chun Hyang University Hospital Seoul